# Cannabinoid Clinical Trials: Cannabis in At-Risk Teens

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/sequential-messaging-cannabis-prevention-at-risk-teens/
> **Published:** 2026-04-14T19:43:26-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:56:14-04:00
> **Clinical Summary:** Explore sequential messaging cannabis prevention strategies tailored for at-risk teens to improve effectiveness over standard anti-cannabis campaigns.

---

#### Clinical Takeaway



Research suggests that standard anti-cannabis messages often fail because they don’t account for the wide range of attitudes adolescents already hold about cannabis. This study tested a sequential messaging approach that first challenged negative reactions to prevention messages before delivering a more targeted follow-up communication, specifically in middle and high school students who had not yet used cannabis. The findings point toward more personalized, rebuttal-based strategies as a potentially more effective framework for [adolescent cannabis](https://cedclinic.com/cannabis-use-disorder-psychiatric-risk/) prevention compared to one-size-fits-all campaigns.









### #28 A Rebuttal-Based Social Norms-Tailored Cannabis Intervention for At-Risk Adolescents.






**Citation:** Donaldson Candice D et al. *A Rebuttal-Based Social Norms-Tailored Cannabis Intervention for At-Risk Adolescents.* Prevention science: the official journal of the Society for Prevention Research. 2021. PMID: 33791930.






**Study type:** Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural  | 

**Topic area:** Pediatrics  | 

**CED Score:** 10






Design: 5 Journal: 0 N: 3 Recency: 0 Pop: 3 Human: 1 Risk: -2






**Quality Gate Alerts:**
- Preclinical only





**Abstract:** Many past cannabis prevention campaigns have proven largely ineffective due in part to the diversity of adolescents’ cannabis-relevant beliefs. The current studies evaluated the impact of a sequential multiple message approach tailored to the usage norms of adolescents expressing negative attitudes toward a cannabis prevention appeal. A multiple-message strategy was implemented-initial unfavorable message evaluations were invalidated using attitudinal rebuttal feedback prior to presenting a third tailored communication. Participants were cannabis-abstinent middle and high school students (ages 11 to 16). Study 1 (N = 808) compared effects of gain- and loss-framed messages tailored to each student’s normative usage perceptions. In Study 2 (N = 391), students were randomly assigned to receive a tailored or non-tailored message after receiving feedback meant to destabilize anti-message attitudes. For at-risk adolescents in Study 1 who perceived [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) as normative, a tailored gain-framed message resulted in the lowest usage intentions (p < .05). In Study 2, a conditional multiple-moderated mediation model showed that for high-risk teens with normative beliefs and pro-cannabis attitudes, exposure to a tailored gain-framed communication was associated with decreased cannabis attitude certainty, and lower usage intentions 2 months later (p < .05). Findings have implications for sequential messaging utilization in mass media campaigns and support the efficacy of tailored messages over a one-size-fits-all media approach. Further, results suggest that systematically weakening resistance to persuasive communications and tailoring messages consistent with individually perceived peer norms is an effective prevention strategy.








 |   | 






[View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/33791930/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257086/)[DOI ↗](https://doi.org/10.1007/s11121-021-01224-9)










 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.
 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 
 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Cannabinoid Clinical Trials: Cannabis Intervention in Teens](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/)

An in-depth look at [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) focusing on cannabis interventions specifically designed for adolescent populations.

[Read More](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/)

[Endocannabinoid System Research: Teen Cannabis Intervention](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/)

Explore research on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and its role in cannabis interventions among teens.

[Explore Research](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/)

[Cannabinoid Clinical Trials: Cannabis Interventions for Teens](https://cedclinic.com/cannabis-interventions-for-teens/)

Review clinical trials evaluating various cannabis intervention methods tailored for adolescent users.

[Learn More](https://cedclinic.com/cannabis-interventions-for-teens/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Cannabinoid%20Clinical%20Trials%3A%20Cannabis%20in%20At-Risk%20Teens&url=https%3A%2F%2Fcedclinic.com%2Fsequential-messaging-cannabis-prevention-at-risk-teens%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fsequential-messaging-cannabis-prevention-at-risk-teens%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Cannabinoid%20Clinical%20Trials%3A%20Cannabis%20in%20At-Risk%20Teens%20https%3A%2F%2Fcedclinic.com%2Fsequential-messaging-cannabis-prevention-at-risk-teens%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
